[HTML][HTML] Current and novel therapeutic molecules and targets in Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
Current and novel therapeutic molecules and targets in Alzheimer's disease.
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2015 - europepmc.org
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
[PDF][PDF] Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2015 - cyberleninka.org
Alzheimer's disease (AD) is one of the most common causes of dementia in the society. AD
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari… - Journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
[引用][C] Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar - J Formos Med Assoc, 2015 - cir.nii.ac.jp
Current and novel therapeutic molecules and targets in Alzheimer's disease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2016 - hero.epa.gov
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the Formosan …, 2016 - infona.pl
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
causes memory loss and cognitive decline, ie, dementia. The disease starts with mild …
[PDF][PDF] Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2016 - scholar.archive.org
Alzheimer's disease (AD) is one of the most common causes of dementia in the society. AD
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
[PDF][PDF] Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2016 - core.ac.uk
Alzheimer's disease (AD) is one of the most common causes of dementia in the society. AD
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
[PDF][PDF] Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma… - Journal of the …, 2016 - academia.edu
Alzheimer's disease (AD) is one of the most common causes of dementia in the society. AD
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …
is generally classified into two types:(1) early onset/familial AD (FAD); and (2) sporadic AD …